مباشر
Clinical OMICsLipid-Protein Biomarker Makes Clinical Debut with Early Ovarian Cancer DetectionEndpoints NewsSensorion axes hearing loss program; Novartis' biomarker data in muscular dystrophyEndpoints NewsCamurus’ second CRL for acromegaly drug; Teva details workforce cutsFierceBiotechFierce Biotech heading to UK to host event amid London Life Sciences WeekEndpoints NewsBiopharma pay report: Top-paid CSOs, CMOs of 2025Endpoints NewsKardigan plans $320M IPO for heart drugs as Nasdaq listings gain steamPharmaVoiceCompetition is brewing between ADCs and bispecificsBioWorldInnovo Therapeutics synthesizes new NMT1 inhibitorsBioWorldShanghai Qingrun Pharmaceutical Technology patents new Mat2A inhibitorsBioWorldSalubris Pharma reports new RXFP1 receptor agonistsBioWorldHelioson discloses new VAV1 degradation inducersBioWorldResearchers hit back after colleagues removed from ADA meeting
Endpoints News ٢٥ نوفمبر ٢٠٢٥

Pharma faces deadline to bring IRA fight to Supreme Court as first set of negotiated prices looms

Pharma faces deadline to bring IRA fight to Supreme Court as first set of negotiated prices looms

المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.